爱维治联合参麦注射液对新生儿缺氧缺血性脑病疗效分析

Clinical analysis of treating hypoxiaischemic encephalopathy of newborn of 50 cases with actoregin and Shenmai injection

目的:探讨爱维治、参麦注射液联合治疗新生儿缺氧缺血性脑病的疗效。方法:新生儿缺氧缺血性脑病150例,随机分为观察组、爱维治组和参麦注射液组各50例。爱维治组给予爱维治100mg/(kg·d),参麦组给予参麦注射液2ml/(kg·d),分别加入10%葡萄糖液中静脉滴注, 1次/d, 7d为一疗程;观察组两药并用。结果:观察组与爱维治组比较总有效率P< 0 05,观察组与参麦注射组比较总有效率P< 0 05,爱维治组与参麦注射液组比较总有效率P> 0 05。结论:爱维治与参麦注射液联用治疗新生儿缺氧缺血性脑病疗效显著。

Objective: To study the curative effect of treating hypoxiaoschemic encephalopathy of newborn with actoregin and shenmai injection. Methods: 150 cases were divided at random into 3 groups: Observation group, Actoregin group, and Shenmai injection group, 50 cases in each group. Actoregin 100 mg/(kg·d) and Shenmai injection 2 ml/(kg·d) were added separately into 10% glucose injection of intravenous drips. One course of treatment is 7 days, once a day. Both of medicines were taken in Abservation group. Results: Compared the observation group with the actoregin group, the total effective rate is P<0.05. Compared the observation group with the shenmai injection group, the rate is P < 0.05. And compared the actoregin group with shenmai injection group, the rate is P > 0.05. Conclusion: Treating hypoxiaischemic encephalopathy of newborn with actoregin and shenmai injection have obvious curative effect.